TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

76 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • COPD (chronic lung disease)

    A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

    Testing two doses of a medicine versus placebo for COPD symptoms

    📍 Research Site · Birmingham, AL · +39 more US sites · Get directions →

    This Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.

    ✓ Study care freePhase 2Ages 40+Learn more →
  • COPD (chronic lung disease)

    Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

    Testing how a genetic change in alpha-1 antitrypsin affects immune and lung responses to a pneumonia

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    The goal of this study is to learn whether patients who have a genetic mutation in the genes that cause alpha 1 antitrypsin deficiency also have genetic variation in nearby genes that can increase risk for reduced immune function and respiratory infections. To investigate this hypothesis, we will compare immune responses to the 20-valent pneumococcal conjugate vaccine (PCV20, Pfizer) between participants who have one abnormal copy of the SERPINA1 gene and either no COPD exacerbations, vs those with 2 or more COPD exacerbations in the past year.

    ✓ Study care freePhase 4Ages 19+Learn more →
  • Rheumatoid arthritis

    Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares

    Comparing pills versus shots of steroids to control rheumatoid arthritis flares

    📍 Sunnybrook Health Sciences Centre · Toronto, Ontario · Get directions →

    People living with rheumatoid arthritis (RA) often experience flares-periods where their symptoms suddenly get worse. These flares can cause significant pain, make it harder to move and do daily activities, and lower overall quality of life.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Migraine / chronic headache

    Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

    Testing rimegepant taken before a known trigger to prevent predictable migraine

    📍 MedStar Health: Neurology at McLean · McLean, VA · Get directions →

    Single-center, open label, prospective study conducted at Medstar Georgetown Headache Center. Men and woman ≥ 18 years old that are diagnosed with migraine with or without aura for at least 1 year, who report a reliable migraine trigger.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Rheumatoid arthritis

    Dynamic Treatment Regiments for Glucocorticoid Tapering

    Studying how people with rheumatoid arthritis respond to tapering steroid medicine

    📍 VA Ann Arbor Healthcare System, Ann Arbor, MI · Ann Arbor, MI · +1 more US site · Get directions →

    The purpose of this clinical trial is to better understand how people with rheumatoid arthritis (RA) respond to gradual dose reduction, or "tapering", of steroid medications like prednisone. Some people with RA have symptoms when steroid dose is reduced, while others don't.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • COPD (chronic lung disease)Asthma

    The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

    Testing whether positive airway pressure helps a lung medicine (NAC) reach mucus plugs in asthma or

    📍 UCSF Airway Clinical Research Center · San Francisco, CA · Get directions →

    The goal of this clinical trial is to determine if positive pressure during inspiration will improve penetration of aerosolized N-Acetylcysteine (NAC) into airway mucus plugs in the lungs of patients with asthma or Chronic Obstructive Pulmonary Disease (COPD). The main questions it aims to answer are: * Does delivery of aerosolized NAC with positive inspiratory pressure have a greater effect on mucus plug burden in the lungs than delivery of NAC without positive pressure.

    ✓ Study care freePhase 4Ages 18–85Learn more →
  • COPD (chronic lung disease)

    To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

    Testing two doses of a daily medicine versus placebo in people with COPD over 52 weeks

    📍 DM Clinical Research - Phoenix · Phoenix, AZ · +11 more US sites · Get directions →

    This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will be randomized to receive either study drug or placebo administered once daily for 52 weeks.

    ✓ Study care freePhase 2Ages 40–85Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

    Testing a CD19-targeted CAR T cell treatment in people with severe lupus or rheumatoid arthritis

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · +30 more US sites · Get directions →

    The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases (Breakfree-1).

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Rheumatoid arthritis

    📍 Artiva Investigational Site Tuscaloosa · Tuscaloosa, AL · +30 more US sites · Get directions →

    A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects to evaluate the safety and efficacy of AlloNK, a non-genetically modified allogeneic NK cell, in combination with rituximab.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    📍 Arizona Arthritis & Rheumatology Associates · Gilbert, AZ · +21 more US sites · Get directions →

    This is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Approximately 180 participants are planned to be enrolled.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Rheumatoid arthritis

    Advanced Therapeutics in Rheumatoid Arthritis (RA)

    Tracking how long two rheumatoid arthritis treatments are kept in adults

    📍 Rheumatology Clinic, St. Joseph's Health Care · London, Ontario · Get directions →

    This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Migraine / chronic headache

    A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

    Testing a medicine shot to treat episodic migraine vs placebo

    📍 Flourish - Birmingham · Birmingham, AL · +15 more US sites · Get directions →

    The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

    ✓ Study care freePhase 2Ages 18–70Learn more →
  • Migraine / chronic headache

    Study of EVO756 in Adults With Migraine

    Testing a medicine called EVO756 compared with placebo in adults with migraine

    📍 CA Medical Clinic for Headache · Los Angeles, CA · +12 more US sites · Get directions →

    This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

    ✓ Study care freePhase 2Ages 18–64Learn more →
  • Rheumatoid arthritis

    A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

    Testing how safe and tolerable an immune-cell treatment is for rheumatoid arthritis

    📍 Nkarta Investigational Site · Orange, CA · +14 more US sites · Get directions →

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

    Testing tadalafil to see if it improves shortness of breath in COPD with high blood pressure in the

    📍 Rocky Mountain Regional VA Medical Center, Aurora, CO · Aurora, CO · +4 more US sites · Get directions →

    The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investigators will also assess whether tadalafil improves quality of life, home daily physical activity, exercise endurance, the frequency of acute flares of COPD, blood pressure in the lungs, and lung function.

    ✓ Study care freePhase 2Ages 35–89Learn more →
  • Rheumatoid arthritis

    Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

    Testing how a single dose works and whether it is safe in people with rheumatoid arthritis

    📍 Mayo Clinic · Scottsdale, AZ · +8 more US sites · Get directions →

    This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Rheumatoid arthritis

    Study of GS-0151 in Participants With Rheumatoid Arthritis

    Testing a study drug in people with rheumatoid arthritis to assess safety

    📍 Pinnacle Research Group, LLC · Anniston, AL · +17 more US sites · Get directions →

    The goal of this clinical study is to learn more about the study drug GS-0151. The study is done to find how safe, well-tolerated the drug is.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Rheumatoid arthritis

    "Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"

    Testing whether vitamin E lowers inflammation and symptoms in rheumatoid arthritis

    📍 Civil Hospital of Guadalajara · Guadalajara, Jalisco · Get directions →

    The objective of this clinical trial is to determine whether α-tocopherol (vitamin E) supplementation decreases inflammation and clinical activity in patients with rheumatoid arthritis (RA).The main questions to be answered are: * Is supplementation with vitamin E (α-tocopherol) for one month associated with decreased clinical activity and inflammation in patients with RA? Researchers will compare α-tocopherol with a placebo (a look-alike substance containing no active ingredient) to see if α-tocopherol effectively reduces inflammation and clinical activity in patients with rheumatoid arthritis.

    ✓ Study care freePhase 2Ages 18+WomenLearn more →
  • Migraine / chronic headache

    Mechanistic Studies of Psilocybin in Headache Disorders

    Testing how psilocybin may affect migraine headache symptoms

    📍 VA Connecticut Healthcare System · West Haven, CT · Get directions →

    In previous clinical trial work, the investigators observed lasting reductions in headache burden after limited dosing of psilocybin. This purpose of this study is to examine potential sources for this observed effect.

    ✓ Study care freeEarly Phase 1Ages 21–70Learn more →
  • COPD (chronic lung disease)

    Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

    Testing an add-on treatment for adults having a COPD flare with type 2 inflammation

    📍 University of Alabama at Birmingham Lung Health Center · Birmingham, AL · +21 more US sites · Get directions →

    This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation

    ✓ Study care freePhase 2Ages 40–80Learn more →
  • COPD (chronic lung disease)

    📍 Equity Medical Bowling Green · Bowling Green, KY · +2 more US sites · Get directions →

    Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Rheumatoid arthritis

    Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)

    Testing ways to see lymph vessels in people with rheumatoid arthritis

    📍 University of Rochester · Rochester, NY · Get directions →

    Lymphatic transport was previously examined by these investigators using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities. They established reliable and reproducible methodologies in RA patients.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Rheumatoid arthritis

    A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

    Testing targeted treatments for people with moderate to severe rheumatoid arthritis

    📍 Sun Valley Arthritis Center /ID# 278331 · Peoria, AZ · +39 more US sites · Get directions →

    Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA).

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

    Testing how a treatment called LY4213663 is tolerated and side effects in people with rheumatoid

    📍 Pinnacle Research Group, LLC · Anniston, AL · +8 more US sites · Get directions →

    The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants with rheumatoid arthritis (RA). The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm).

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Rheumatoid arthritis

    A Study of AZD0120 in Autoimmune Diseases

    Testing safety of a gene-cell treatment in adults with hard-to-treat rheumatoid arthritis

    📍 Research Site · Tucson, AZ · +7 more US sites · Get directions →

    This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arthritis (D2T RA).

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • COPD (chronic lung disease)

    A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

    Testing different doses of two inhaled medicines for COPD symptoms

    📍 SEC Clinical Research, LLC · Dothan, AL · +39 more US sites · Get directions →

    This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual components of the fixed dose combinations, each administered twice a day via standard jet nebulizer, in adult subjects with chronic obstructive pulmonary disease (COPD).

    ✓ Study care freePhase 2Ages 40–80Learn more →
  • COPD (chronic lung disease)

    Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

    Comparing inhaled triple versus double medicines for COPD lung airways after wood smoke exposure

    💵 May compensate

    📍 Insituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" · Mexico City, Tlalpan · Get directions →

    This phase IV randomized controlled clinical trial intend to compare the effect of three close standard inhaled triple therapies and one close standard inhaled double therapy on the small airway in patients with Chronic Obstructive Pulmonary Disease (COPD-B) and chronic bronchitis without obstruction (BCNO) exposed to wood smoke. The treatment phase duration is of 3 months.

    ✓ Study care freePhase 4Ages 35–85WomenLearn more →
  • COPD (chronic lung disease)

    Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

    Comparing nebulizer and inhaler treatments for COPD symptoms

    📍 The University of Tennessee Graduate School of Medicine · Knoxville, TN · Get directions →

    The purpose of this study is to compare the effectiveness of inhaled bronchodilators delivered via nebulizers vs. dry powder inhalers (DPIs) in symptomatic participants with Chronic Obstructive Pulmonary Disease (COPD) who have airflow obstruction (FEV1/FVC ≤ 70%) and show significant air trapping (RV ≥ 120% of predicted).

    ✓ Study care freePhase 4Ages 40+Learn more →
  • Migraine / chronic headache

    A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

    Comparing a migraine medicine tablet that dissolves in the mouth to another for adults with migraine

    📍 Maimonides Medical Center · Brooklyn, NY · Get directions →

    Rimegepant (Nurtec) is an orally administered small molecule CGRP receptor antagonist with efficacy in the acute treatment of migraine. Rizatriptan benzoate (MAXALT), is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.

    ✓ Study care freePhase 4Ages 18–65Learn more →
  • Lupus (SLE)Rheumatoid arthritisCrohn's / ulcerative colitis (IBD)

    COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

    Testing COVID-19 booster and flu vaccine schedules in people with lupus, rheumatoid arthritis, or

    📍 Maisonneuve -Rosemont Installation · Montreal, Quebec · Get directions →

    The goal of this pragmatic embedded open-label, 2 x 2 factorial phase II randomized controlled trial is to evaluate strategies to improve COVID-19 booster and influenza vaccine immunogenicity in people living with immunocompromising conditions (PLIC). The main questions it aims to answer are: 1.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • COPD (chronic lung disease)

    A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

    Testing how a study medicine affects safety and symptoms in people with COPD

    📍 University of Alabama at Birmingham Lung Health Center · Birmingham, AL · +39 more US sites · Get directions →

    The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected.

    ✓ Study care freePhase 2Ages 35–80Learn more →
  • COPD (chronic lung disease)

    A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

    Testing the safety and effects of an inhaled medicine for COPD

    📍 University of Alabama at Birmingham · Birmingham, AL · +6 more US sites · Get directions →

    This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Obesity / overweightHigh blood pressureCOPD (chronic lung disease)

    Feasibility of Semaglutide in Advanced Lung Disease

    Testing whether semaglutide can be given safely to people with advanced lung disease

    📍 University of Pennsylvania Perelman School of Medicine · Philadelphia, PA · Get directions →

    The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung disease. The main question\[s\] it aims to answer are: 1.

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • COPD (chronic lung disease)

    A Study to Evaluate Solrikitug in Participants With COPD (ZION)

    Testing solrikitug in people with COPD to check safety and effects

    📍 University of Alabama at Birmingham Hospital · Birmingham, AL · +39 more US sites · Get directions →

    A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstructive Pulmonary Disease (COPD).

    ✓ Study care freePhase 2Ages 40–75Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    📍 Pinnacle Research Group /ID# 278677 · Anniston, AL · +9 more US sites · Get directions →

    Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Migraine / chronic headache

    A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

    Testing how safe it is to take an extra dose of rimegepant for migraine

    📍 Hope Clinical Research · Canoga Park, CA · +6 more US sites · Get directions →

    Acute treatments for migraine may not provide sufficient pain relief after an initial dose, and a second dose of a given medication may be needed to fully abort an attack. International Headache Society (IHS) global practice recommendations for the Acute Treatment of Migraine suggest a second dose of the same medication within the recommended dose limit in people with headache relapse after successful initial treatment of a migraine attack.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Rheumatoid arthritis

    An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

    Testing the long-term safety and results of afimkibart in rheumatoid arthritis

    📍 DM Clinical Research · Tomball, TX · Get directions →

    The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    📍 SunValley Arthritis Center Ltd. · Peoria, AZ · +11 more US sites · Get directions →

    This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Migraine / chronic headache

    Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

    Testing whether a migraine attack medicine works and is tolerated in people using preventive CGRP

    📍 Mayo Clinic in Arizona · Phoenix, AZ · Get directions →

    Zavegepant (Zavzpret) is approved for the acute treatment of migraine with or without aura in the US. The purpose of this study is to investigate the effectiveness and tolerability of zavegepant for the acute treatment of migraine attacks amongst participants who are using calcitonin gene-related peptide (CGRP) migraine preventive treatments.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Migraine / chronic headache

    Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines

    Testing lidocaine delivered into skull blood vessels to treat chronic migraines

    📍 Neuroscience Institute at Great Neck · Great Neck, NY · Get directions →

    The main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic migraine intensity, frequency, and duration.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

    Testing a study medicine for safety in people with lupus or rheumatoid arthritis

    📍 Gold Coast University Hospital ( Site 1601) · Southport, Queensland · Get directions →

    This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • COPD (chronic lung disease)

    A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

    Testing the right dose of a long-acting medicine for moderate to severe COPD

    📍 WB Contracted Clinical Research Site · Miami Lakes, FL · +3 more US sites · Get directions →

    This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD). WIN378 blocks the action of a protein called TSLP that causes inflammation in the lung and may contribute to COPD control and symptoms.

    ✓ Study care freePhase 2Ages 40–80Learn more →
  • Migraine / chronic headache

    📍 Sunwise Clinical Research, Llc · Walnut Creek, CA · +2 more US sites · Get directions →

    This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the study.

    ✓ Study care freePhase 2Ages 18–65Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

    Testing how safe inebilizumab and blinatumomab are in adults with lupus or rheumatoid arthritis

    📍 HonorHealth Research and Innovation Institute · Scottsdale, AZ · +16 more US sites · Get directions →

    The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to assess the safety and tolerability of subcutaneous (SC) blinatumomab in adult participants with active and refractory SLE with and without nephritis (Subprotocol B Part A) and in adult participants with active refractory rheumatoid arthritis (RA) (Subprotocol C Part A). The trial will also assess the efficacy of SC blinatumomab in adult participants with active and refractory SLE with and without nephritis (Subprotocol B Part B and Subprotocol C Part B).

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

    Testing safety and effects of AB-101 with rituximab in lupus and rheumatoid arthritis

    📍 IRIS Research and Development, LLC · Plantation, FL · Get directions →

    This study will evaluate the safety and activity of AB-101 in combination with rituximab in B-cell associated autoimmune diseases where rituximab is currently FDA approved (e.g., Rheumatoid Arthritis (RA), Pemphigus Vulgaris (PV), Granulomatosis with polyangiitis (GPA)/microscopic polyangiitis (MPA) as a therapeutic, or is recommended (e.g., in Systemic Lupus Erythematosus (SLE) as a cornerstone for disease management.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

    Testing the safety and side effects of surovatamig in adults with RA or lupus

    📍 Research Site · Birmingham, AL · +4 more US sites · Get directions →

    This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE.

    ✓ Study care freePhase 1Ages 18–65Learn more →
  • Migraine / chronic headache

    A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

    Testing the safety and effects of IPN10200 to prevent migraine in adults

    📍 Central Research Associates · Birmingham, AL · +39 more US sites · Get directions →

    A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Migraine / chronic headache

    Cannabis for the Prophylactic Treatment of Migraine

    Testing whether cannabis lowers the frequency of chronic migraine

    📍 CHAMP Research (Calgary Headache Assessment & Management Program) · Calgary, Alberta · Get directions →

    This study will evaluate the efficacy and safety of cannabis for the treatment of chronic migraine headaches. Study subjects will be randomized to one of three groups: lower dose CBD, higher dose CBD or placebo.

    ✓ Study care freePhase 2Ages 25+Learn more →
  • Rheumatoid arthritis

    📍 Nouvelle Clinical Research LLC · Cutler Bay, FL · +2 more US sites · Get directions →

    The study is a randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral AP1189 administered at the doses of 40, 70, or 100 mg for 12 weeks in combination with methotrexate, in DMARD-naïve participants with early rheumatoid arthritis and active inflammation.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • COPD (chronic lung disease)

    The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)

    Studying how sleep apnea together with COPD affects heart health

    📍 UCSD Sleep Research · La Jolla, CA · Get directions →

    Major progress has been made in the area of cardiovascular disease, but we believe that further progress will involve mechanistically addressing underlying respiratory causes including chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA). The most common cause of death in COPD is cardiovascular, although mechanisms are unknown.

    ✓ Study care freePhase 2Ages 40–79Learn more →
  • Migraine / chronic headache

    Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial

    Testing cannabis for chronic migraines in adolescents

    📍 University of British Columbia · Vancouver, British Columbia · Get directions →

    Chronic headaches are a major cause of disability among adolescents. Cannabis products have supported the management of headaches in adults and may play a role in pediatric chronic pain.

    ✓ Study care freePhase 2Ages 14–17Learn more →
  • Rheumatoid arthritis

    A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

    Testing how well and how safely AZD1163 works for people with rheumatoid arthritis

    📍 Research Site · Glendale, AZ · +27 more US sites · Get directions →

    Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    MAD Study of IA-14069

    Testing the safety and dose effects of an oral medicine in healthy people and people with rheumatoid

    📍 ICON plc. · Lenexa, KS · Get directions →

    The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending oral doses of IA-14069 in healthy subjects and in patients with RA on stable dosese of MTX, with preliminary assessment of efficacy in RA patients.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Migraine / chronic headache

    Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

    Testing whether a nerve block plus steroid tablets lowers migraine headache return within 72 hours

    📍 University Medical Center of El Paso · El Paso, TX · Get directions →

    For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

    ✓ Study care freeEarly Phase 1Ages 18–85Learn more →
  • Rheumatoid arthritis

    Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

    Testing reduced-intensity transplant approaches for people with rheumatoid arthritis

    📍 UPMC Children's Hospital of Pittsburgh · Pittsburgh, PA · Get directions →

    The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). After transplant, subjects will be followed for late effects and for ongoing graft success.

    ✓ Study care freePhase 2Learn more →
  • Heart / cardiovascular diseaseHigh blood pressureCOPD (chronic lung disease)

    : Vascular Function in Health and Disease

    Studying how blood vessel function works in health and diseases like heart problems, high blood

    📍 George E Wahlen VA Medical Center · Salt Lake City, UT · Get directions →

    Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of vasomotion and thus perfusion to the muscle tissue is the host of chemical factors originating from the vascular endothelium and the muscle tissue, which collectively sets the level of vascular tone.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • COPD (chronic lung disease)

    Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

    Comparing a lung scan that uses xenon MRI with a radioactive scan for COPD

    📍 University of Virginia Health System · Charlottesville, VA · Get directions →

    Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with intention to conduct a larger clinical trial.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • COPD (chronic lung disease)

    Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

    Testing whether lung transplant first can improve lung function before bone marrow transplant for

    📍 UPMC Presbyterian · Pittsburgh, PA · +1 more US site · Get directions →

    The purpose of this study is to determine whether a lung transplantation prior to bone marrow transplantation (BMT) would allow for restoration of pulmonary function prior to BMT, allowing to proceed to BMT, to restore hematologic function.

    ✓ Study care freePhase 1Ages 18–60Learn more →
  • Lupus (SLE)Rheumatoid arthritisMultiple sclerosis (MS)

    Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    Testing nivolumab for side effects and cancer response in people with advanced cancer and autoimmune

    📍 University of Alabama at Birmingham Cancer Center · Birmingham, AL · +39 more US sites · Get directions →

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from where it first started (primary site) to nearby tissue, lymph nodes, or distant parts of the body (advanced), to other places in the body (metastatic) or cannot removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • High blood pressureCOPD (chronic lung disease)Asthma

    Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

    Testing a lung scan method using hyperpolarized oxygen gas MRI in healthy and people with COPD or

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

    ✓ Study care freePhase 1Ages 3+Learn more →
  • Showing the first 60 of 76. Add filters or a location to narrow down.